Edition:
United States

Quest Diagnostics Inc (DGX.N)

DGX.N on New York Stock Exchange

111.18USD
21 Jun 2018
Change (% chg)

$0.46 (+0.42%)
Prev Close
$110.72
Open
$110.65
Day's High
$111.34
Day's Low
$110.24
Volume
167,549
Avg. Vol
270,473
52-wk High
$112.83
52-wk Low
$90.21

Chart for

About

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates through two businesses: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower... (more)

Overall

Beta: 0.69
Market Cap(Mil.): $15,030.89
Shares Outstanding(Mil.): 135.82
Dividend: 0.50
Yield (%): 1.81

Financials

  DGX.N Industry Sector
P/E (TTM): 22.89 30.10 34.04
EPS (TTM): 4.84 -- --
ROI: 7.92 7.77 13.11
ROE: 14.00 11.12 15.11

BRIEF-Quest Diagnostics Adds Helen Torley To Board Of Directors

* QUEST DIAGNOSTICS - HELEN TORLEY ELECTED TO SERVE AS DIRECTOR AT CO'S 2018 ANNUAL MEETING OF STOCKHOLDERS, EXPANDING BOARD OF DIRECTORS TO 10 MEMBERS Source text for Eikon: Further company coverage:

May 17 2018

BRIEF-Quest Diagnostics Says CEO Rusckowski's 2017 Total Compensation Was $10.35 Mln Vs $10.25 Mln In 2016 ‍​

* QUEST DIAGNOSTICS INC SAYS CEO STEPHEN H. RUSCKOWSKI'S 2017 TOTAL COMPENSATION WAS $10.35 MILLION VERSUS $10.25 MILLION IN 2016 – SEC FILING ‍​ Source text: (https://bit.ly/2uKsWVj) Further company coverage:

Apr 04 2018

BRIEF-Quest, Humana, Multiplan, Optum, UnitedHealthcare Launch Blockchain Program

* Quest - CO, HUMANA, MULTIPLAN, UNITEDHEALTH GROUP'S OPTUM, UNITEDHEALTHCARE LAUNCH BLOCKCHAIN PROGRAM TO IMPROVE DATA QUALITY AMONG OTHERS Source text for Eikon: Further company coverage:

Apr 02 2018

BRIEF-Genomic Vision Extends Its Collaboration With Quest Diagnostics​

* ‍GENOMIC VISION EXTENDS ITS COLLABORATION WITH QUEST DIAGNOSTICS IN SPINAL MUSCULAR ATROPHY (SMA)​

Mar 14 2018

BRIEF-Quest Diagnostics Reports Q4 Adjusted Earnings Per Share $1.40

* QUEST DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS; PROVIDES GUIDANCE FOR FULL YEAR 2018; INCREASES DIVIDEND 11% TO $0.50 PER QUARTER

Feb 01 2018

Competitors

Earnings vs. Estimates